RE:RE:CC invoices unpaid go as receivables and get counted in the Quarter, maybe the last day of the quarter would be forwarded although that is why reporting is 45 days after quarter end so they have all invoices out and accounted for
Skrit37 wrote:
SAGDollar wrote: Granted this is an analyst call but what questions do you guys have? Im rather contempt with the status and current progression of their covid testing. I would like to know if they have any intended marketing coming up for Aristotle in addition to just a status update and maybe some details on partnerships. I look at Sona investors and feel for them today. That's the nature of these stocks. However SZLS has taken one step out of that uncertainty with revenue confirmed from covid testing. Now investors just need a few hints at the significance and validity of Aristotle and this will be a runaway train. It's a weird feeling now tho. I'm happier than I have ever been with SZLS, but the share price is dog sh!t. It's only a matter of time before the inevedibale corrections begins. A full subscription on the pp would be a good start.
Anything.... and everything..... in any way related to Aristotle...LDT/FDA timeline / status esspecially...
We know covid is doing very well....its a money printing/partnership/advertising machine .....ive stated before...which was comfirmed by the company....there is revenue incomming that was produced in Q3 but could not be realized due to it being invoiced...i think we will all be amazed how large this sum this will be seeing we have be scalling testing drastically.......
Aristotle is were our future is...and thats the most important info we can hear about IMO
Goodluck folks